Sono-Tek is trading at $5.85, down 17.70%, after Q2 fiscal 2027 results missed expectations.
- EPS was $0.02 vs. $0.04 expected; revenue was $5.23 million vs. $5.56 million. The report linked the premarket selloff to results.
- Revenue rose 1% year over year and net income fell 14%; management reiterated full-year guidance for flat to modest growth.
- Medical sales surged 209% and backlog grew, but those positives did not prevent the market reaction.